UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF INCOME
Sales, net (notes 1, 3, 9 and 11)	$ 50,224	$ 52,281	$ 49,054
Cost of goods sold	20,186	20,085	18,137
Gross profit	30,038	32,196	30,917
Sales and marketing	1,685	1,507	1,414
Research and development	560	493	526
General and administrative	11,016	10,406	10,097
Operating income	16,777	19,790	18,880
Dividend and interest income	3,036	661	166
Royalty income (note 12)	20	20	15
Other, net	256	188	0
Income before provision for income taxes	20,089	20,659	19,061
Provision for income taxes (note 7)	3,454	4,186	4,273
Net income	$ 16,635	$ 16,473	$ 14,788
Earnings per common share (basic) (note 1)	$ 4.58	$ 4.53	$ 4.05
Earnings per common share (diluted) (note 1)	$ 4.57	$ 4.52	$ 4.04
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ 1,381	$ (2,986)	$ (773)
Total comprehensive income	$ 18,016	$ 13,487	$ 14,015